Skip to main content
SpringerLink
Log in

The System of Objective Judgement Analysis Method: Less Objectivity Than Pretended?

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Janknegt R. Fluoroquinolones: use of clinical data to aid formulary choice by the System of Objective Judgement Analysis (SOJA) method. Phannacoeconomics 1994: 6 (1): 15–33

    Article  CAS  Google Scholar 

  2. Fink MP, Syndman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomised, double–blind trial comparing intravenous ciprofloxacin with imipenem–cilastatin. Antimicrob Agents Chemother 1994; 38 (3): 547–57

    Article  PubMed  CAS  Google Scholar 

  3. Solomkin J, Reinhart H. Results of a trial of IV + PO ciprofloxacin/metronidazole versus imipenem for complicated in Intraabdominal infections [abstract]. Proceedings of the 34th Interseience Conference on Antimicrobial Agents and Chemotherapy; 1994 Oct 4-7: Orlando (FL). Washington, DC: American Society for Microbiology, 1994

    Google Scholar 

  4. Christ W, Esch B. Adverse reactions to fluoroquinolones in adults and children. Infect Dis Clin Pract 1994; 3 Suppl. 1: 51–9

    Google Scholar 

  5. Beermann D, Wingender W, Zeiler HJ. et al. Comparative pharmacokinetics of three new quinoline carboxylic acid antibiotics after oral administration in healthy volunteers. J Clin Phamacol 1984; 24: 403–9

    Google Scholar 

  6. Janknegt R, Wijnands WJA, Caprase M, et al. Antimicrobial drug use in hospitals in the Netherlands. Germany and Belgium. Eur j Clin Microbiol lnfect Dis 1993: 12: 832–8

    Article  CAS  Google Scholar 

  7. Soltan A, Khan AF, Mir J. Safety and efficacy of parenteral ofloxacin vs ceftazidime in the treatment of moderate to severe pneumonia. In: Ofloxacin. Proceedings of the 3rd International Syrnposium on New Quinolones; 1990 Jul 12–14: Vancouver. Eur J Clin Microbiol Infect Dis 1991: 10: 79

    Google Scholar 

  8. Lam WK, Chau PY, Cham JC. Ofloxacin vs cefuruxime in the treatment of lower respiratory tract infections in moderately immunocompromised patients. Drugs 1993; 45 Suppl.3: 416–7

    Article  Google Scholar 

  9. Basaaris HP, Chrysanthopoulos CJ, Skoutelis AT. Once–daily IV and oral ofloxacin versus twice–daily iv and oral ciprofloxacin in the treatment of severe bacterial infections. Proceedings of the 18th International Congress on Chemotherapy; 1993 Jun27–Jul 2: Stockholm. In Recent advances in chemotherapy. American Society for Microbiology, 1994: 510–1

    Google Scholar 

  10. Uzun O, Sedghi S, Ozsut H, et al. Comparative efficacies in iv ofloxacin once a day and ciprofloxacin twice a day in the treatment of moderate to severe infections. Proceedings of the 18th International Congress on Chemotherapy; 1993 Jun 27–Jul 2: Stockholm. In: Recent: advances in chemotherapy. American Society for Microbiology. 1994: 419

  11. Kitzes-Cohen R, Laor A, Once–daily ofloxacin versus twice–daily ciprofloxacin in the treatment of hospital infections. Drugs 1993; 45 Suppl. 3: 446–7

    Article  Google Scholar 

  12. Chrysanthopoulos CJ, Skoutelis AT. Comparative study of once–daily iv/oral ciprofloxacin versus twice–daily iv/oral ciprofloxacin in the treatment of serious bacterial infections [abstract]. 18th International Congress on Chemotherapy; 1993 Jun 27–JuI 2: Stockholm.

    Google Scholar 

  13. Watanabe Y, Ebert S, Graig W. The AUC/MIC ratio is a unifying parameter for comparison of in–vitro activity among fluoroquinolones [abstract no. 42]. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1992 Oct 11–14: Anaheim (CA). Washington, DC: American Society for Microbiology

  14. Forrest A, Nix DE, Bellow CH, et al. Pharmacodynamics of iv ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1992; 37: 1073–81

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Project Management International, Wuppertal, Germany

    Peter Schacht, Dietrich Bosse, Rolf Kubin & Bayer Ag

  2. Department of Clinical Pharmacy, Maasland Hospital Sittard, The Netherlands

    Robert Janknegt

Authors
  1. Peter Schacht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dietrich Bosse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rolf Kubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bayer Ag
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert Janknegt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schacht, P., Bosse, D., Kubin, R. et al. The System of Objective Judgement Analysis Method: Less Objectivity Than Pretended?. Pharmacoeconomics 7, 180–182 (1995). https://doi.org/10.2165/00019053-199507020-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507020-00009

Keywords

Search

Navigation